Correlation Between Monopar Therapeutics and 594918BB9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and 594918BB9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and 594918BB9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and MICROSOFT P 27, you can compare the effects of market volatilities on Monopar Therapeutics and 594918BB9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of 594918BB9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and 594918BB9.

Diversification Opportunities for Monopar Therapeutics and 594918BB9

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Monopar and 594918BB9 is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and MICROSOFT P 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MICROSOFT P 27 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with 594918BB9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MICROSOFT P 27 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and 594918BB9 go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and 594918BB9

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 19.58 times more return on investment than 594918BB9. However, Monopar Therapeutics is 19.58 times more volatile than MICROSOFT P 27. It trades about 0.4 of its potential returns per unit of risk. MICROSOFT P 27 is currently generating about -0.16 per unit of risk. If you would invest  2,516  in Monopar Therapeutics on November 8, 2024 and sell it today you would earn a total of  2,361  from holding Monopar Therapeutics or generate 93.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Monopar Therapeutics  vs.  MICROSOFT P 27

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
MICROSOFT P 27 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MICROSOFT P 27 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 594918BB9 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and 594918BB9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and 594918BB9

The main advantage of trading using opposite Monopar Therapeutics and 594918BB9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, 594918BB9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 594918BB9 will offset losses from the drop in 594918BB9's long position.
The idea behind Monopar Therapeutics and MICROSOFT P 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets